Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun-Sol | - |
dc.contributor.author | Lee, Dong-Sung | - |
dc.contributor.author | Pandeya, Prakash Raj | - |
dc.contributor.author | Kim, Youn-Chul | - |
dc.contributor.author | Kang, Dae-Gil | - |
dc.contributor.author | Lee, Ho-Sub | - |
dc.contributor.author | Oh, Byung-Chul | - |
dc.contributor.author | Lee, Dae Ho | - |
dc.date.available | 2020-02-27T17:42:51Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 1226-4512 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5766 | - |
dc.description.abstract | Sodium butyrate (SB) has various metabolic actions. However, its effect on dipeptidyl peptidase 4 (DPP-4) needs to be studied further. We aimed to evaluate the metabolic actions of SB, considering its physiologically relevant concentration. We evaluated the effect of SB on regulation of DPP-4 and its other metabolic actions, both in vitro (HepG2 cells and mouse mesangial cells) and in vivo (high fat diet [HFD]-induced obese mice). Ten-week HFD-induced obese C57BL/6J mice were subjected to SB treatment by adding SB to HFD which was maintained for an additional 16 weeks. In HepG2 cells, SB suppressed DPP-4 activity and expression at sub -molar concentrations, whereas it increased DPP-4 activity at a concentration of 1,000 mu M. In HFD-induced obese mice, SB decreased blood glucose, serum levels of insulin and IL 1 beta, and DPP-4 activity, and suppressed the increase in body weight. On the contrary, various tissues including liver, kidney, and peripheral blood cells showed variable responses of DPP-4 to SB. Especially in the kidney, although DPP-4 activity was decreased by SB in HFD-induced obese mice, it caused an increase in mRNA expression of TNF-alpha, IL-6, and IL-1 beta. The pro-inflammatory actions of SB in the kidney of HFD-induced obese mice were recapitulated by cultured mesangial cell experiments, in which SB stimulated the secretion of several cytokines from cells. Our results showed that SB has differential actions according to its treatment dose and the type of cells and tissues. Thus, further studies are required to evaluate its therapeutic relevance in metabolic diseases including diabetes and obesity. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
dc.relation.isPartOf | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
dc.subject | CHAIN FATTY-ACIDS | - |
dc.subject | HISTONE DEACETYLASE INHIBITORS | - |
dc.subject | TYPE-2 DIABETES-MELLITUS | - |
dc.subject | GLUCAGON-LIKE PEPTIDE-1 | - |
dc.subject | ENERGY-METABOLISM | - |
dc.subject | INSULIN SENSITIVITY | - |
dc.subject | EPITHELIAL-CELLS | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | CARCINOMA-CELLS | - |
dc.subject | DPP-IV | - |
dc.title | Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000408518400007 | - |
dc.identifier.doi | 10.4196/kjpp.2017.21.5.519 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, v.21, no.5, pp.519 - 529 | - |
dc.identifier.kciid | ART002260133 | - |
dc.identifier.scopusid | 2-s2.0-85029172573 | - |
dc.citation.endPage | 529 | - |
dc.citation.startPage | 519 | - |
dc.citation.title | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
dc.citation.volume | 21 | - |
dc.citation.number | 5 | - |
dc.contributor.affiliatedAuthor | Oh, Byung-Chul | - |
dc.contributor.affiliatedAuthor | Lee, Dae Ho | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Dipeptidyl peptidase 4 | - |
dc.subject.keywordAuthor | HepG2 cells | - |
dc.subject.keywordAuthor | Mesangial cells | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Sodium butyrate | - |
dc.subject.keywordPlus | CHAIN FATTY-ACIDS | - |
dc.subject.keywordPlus | HISTONE DEACETYLASE INHIBITORS | - |
dc.subject.keywordPlus | TYPE-2 DIABETES-MELLITUS | - |
dc.subject.keywordPlus | GLUCAGON-LIKE PEPTIDE-1 | - |
dc.subject.keywordPlus | ENERGY-METABOLISM | - |
dc.subject.keywordPlus | INSULIN SENSITIVITY | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | CARCINOMA-CELLS | - |
dc.subject.keywordPlus | DPP-IV | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Physiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Physiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.